Literature DB >> 21359104

Increased blood pressure after abrupt cessation of daily cannabis use.

Ryan Vandrey1, Annie Umbricht, Eric C Strain.   

Abstract

OBJECTIVE: Cannabis is the most widely used illicit drug. Acute cannabis administration increases blood pressure (BP) and heart rate and tolerance develops to these effects with heavy use. A valid and reliable withdrawal syndrome occurs in most daily users, but few studies have assessed the cardiovascular effects of withdrawal. The objective of this report is to describe unexpected changes in cardiovascular function during brief periods of supervised cannabis use and abstinence in daily cannabis users.
METHODS: A within-subjects ABAC crossover study in which inpatient volunteers smoked cannabis ad libitum (A), and abstained from cannabis (B/C). Vital signs were obtained 3 times daily during 11 inpatient days for 13 daily cannabis users (11 men, 8 African American).
RESULTS: BP increased significantly during periods of cannabis abstinence compared with periods of cannabis use. The magnitude of increase was substantial in a subset (N = 6) of participants, with mean increases of up to 22.8 mm Hg systolic and 12.3 mm Hg diastolic BP observed. A main effect of heart rate was not observed. Secondary analysis limited to morning assessments suggested that resting heart rate increased during abstinence, but the magnitude of this effect was not clinically significant.
CONCLUSIONS: Abrupt cessation of heavy cannabis use may cause clinically significant increases in BP in a subset of users. BP should be monitored among those attempting to reduce or quit frequent cannabis use, particularly those with preexisting hypertension. The time course of this effect is currently unknown and requires further study.

Entities:  

Keywords:  Blood Pressure; Cannabis; Hypertension; Marijuana; Withdrawal

Mesh:

Substances:

Year:  2011        PMID: 21359104      PMCID: PMC3045206          DOI: 10.1097/ADM.0b013e3181d2b309

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  19 in total

1.  Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion.

Authors:  N L Benowitz; R T Jones
Journal:  Clin Pharmacol Ther       Date:  1975-09       Impact factor: 6.875

Review 2.  The marijuana withdrawal syndrome: diagnosis and treatment.

Authors:  Margaret Haney
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

Review 3.  Review of the validity and significance of cannabis withdrawal syndrome.

Authors:  Alan J Budney; John R Hughes; Brent A Moore; Ryan Vandrey
Journal:  Am J Psychiatry       Date:  2004-11       Impact factor: 18.112

Review 4.  Cardiovascular system effects of marijuana.

Authors:  Reese T Jones
Journal:  J Clin Pharmacol       Date:  2002-11       Impact factor: 3.126

5.  Cannabis and cardiotoxicity.

Authors:  Steven B Karch
Journal:  Forensic Sci Med Pathol       Date:  2006-03       Impact factor: 2.007

6.  Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance.

Authors:  S J Heishman; M L Stitzer; J E Yingling
Journal:  Pharmacol Biochem Behav       Date:  1989-09       Impact factor: 3.533

Review 7.  The cannabis withdrawal syndrome.

Authors:  Alan J Budney; John R Hughes
Journal:  Curr Opin Psychiatry       Date:  2006-05       Impact factor: 4.741

8.  The time course and significance of cannabis withdrawal.

Authors:  Alan J Budney; Brent A Moore; Ryan G Vandrey; John R Hughes
Journal:  J Abnorm Psychol       Date:  2003-08

9.  Cardiovascular and metabolic considerations in prolonged cannabinoid administration in man.

Authors:  N L Benowitz; R T Jones
Journal:  J Clin Pharmacol       Date:  1981 Aug-Sep       Impact factor: 3.126

10.  Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans.

Authors:  L D Chait; J P Zacny
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more
  9 in total

1.  Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.

Authors:  Lisa K Brents; Anna Gallus-Zawada; Anna Radominska-Pandya; Tamara Vasiljevik; Thomas E Prisinzano; William E Fantegrossi; Jeffery H Moran; Paul L Prather
Journal:  Biochem Pharmacol       Date:  2012-01-18       Impact factor: 5.858

2.  Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers.

Authors:  Margaret Haney; Ziva D Cooper; Gillinder Bedi; Evan Herrmann; Sandra D Comer; Stephanie Collins Reed; Richard W Foltin; Frances R Levin
Journal:  Addict Biol       Date:  2018-04-16       Impact factor: 4.280

Review 3.  Role of cannabis in cardiovascular disorders.

Authors:  Hemant Goyal; Hamza H Awad; Jalal K Ghali
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

4.  Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal.

Authors:  Ryan Vandrey; Michael T Smith; Una D McCann; Alan J Budney; Erin M Curran
Journal:  Drug Alcohol Depend       Date:  2011-02-05       Impact factor: 4.492

5.  Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse.

Authors:  Margaret Haney; Ziva D Cooper; Gillinder Bedi; Suzanne K Vosburg; Sandra D Comer; Richard W Foltin
Journal:  Neuropsychopharmacology       Date:  2013-02-26       Impact factor: 7.853

6.  Stress system changes associated with marijuana dependence may increase craving for alcohol and cocaine.

Authors:  Helen C Fox; Keri L Tuit; Rajita Sinha
Journal:  Hum Psychopharmacol       Date:  2012-12-28       Impact factor: 1.672

Review 7.  Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms.

Authors:  Marieka V DeVuono; Linda A Parker
Journal:  Cannabis Cannabinoid Res       Date:  2020-06-05

8.  Differential physiological changes following internet exposure in higher and lower problematic internet users.

Authors:  Phil Reed; Michela Romano; Federica Re; Alessandra Roaro; Lisa A Osborne; Caterina Viganò; Roberto Truzoli
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

Review 9.  Cannabinoids in arterial, pulmonary and portal hypertension - mechanisms of action and potential therapeutic significance.

Authors:  Barbara Malinowska; Marek Toczek; Anna Pędzińska-Betiuk; Eberhard Schlicker
Journal:  Br J Pharmacol       Date:  2018-04-14       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.